Table 2.
Number of Intrusive Memories (IMs) | Delayed arm (n = 39) | Immediate arm (n = 36) | ITT Treatment Effect Estimate | |||
---|---|---|---|---|---|---|
IRR | 95% CI | |||||
Primary Outcome (Week 4) – Between Arm Comparison | ||||||
Median, IQR | 10.00 | (6.0, 17.0) | 1.00 | (0.0, 3.0) | 0.31*** | 0.20, 0.48 |
Mean, SD | 12.46 | 9.28 | 4.03 | 10.68 | ||
Secondary Outcome (Week 8, after crossovera) - Within Delayed Arm Comparison | ||||||
Median, IQR | 1.00 | (0.0, 2.50) | 0.31*** | 0.21, 0.45 | ||
Mean, SD | 3.78 | 7.23 | ||||
Baseline/Run-In Week | ||||||
Median, IQR | 14.00 | (8.0, 19.0) | 14.50 | (10.0, 21.50) | ||
Mean, SD | 17.08 | 15.84 | 18.50 | 13.61 |
Treatment effects presented for between-arm comparison of number of intrusive memories at week 4 (primary outcome), and within delayed arm comparison of number of intrusive memories at week 8 (after crossover) from week 4. Median (IQR) and Mean (s.d.) of number of intrusive memories at baseline, week 4, and week 8 are also presented.
ITT intention to treat, IRR incidence rate ratio, CI confidence interval, IQR interquartile range, SD standard deviation.
***p < 0.001;
aITT treatment effect estimate within the delayed arm after crossover (weeks 4–8).